Goldfinch Bio Partners with Gilead Sciences on Novel Therapies for Kidney Disease

Posted by ISPE Boston
On May 23, 2019

Gilead Sciences and Goldfinch Bio have announced a strategic collaboration to discover, develop and commercialize a pipeline of innovative therapeutics for diabetic kidney disease (DKD) and certain orphan kidney diseases. Under the multi-year collaboration, Gilead has exclusive options to license worldwide rights to certain products directed toward targets emerging from Goldfinch’s proprietary Kidney Genome Atlas™ (KGA), […]

Industry Leaders Provide Chapter with Ideas for the Future

Posted by Kevin Chronley
On May 16, 2019

The spring weather may have been gloomy but spirits were high as the Boston Area Chapter launched its inaugural “Spring Conference” at the Newton Marriott with our continuing series of biopharma industry Advisory Council sessions. The objective of this interactive breakfast workshop was to gather insights from biopharma industry leaders on how to enhance the […]

ElevateBio Launches with $150M in Series A Financing

Posted by ISPE Boston
On May 16, 2019

ElevateBio has established ElevateBio BaseCamp, a single R&D, process development and cGMP manufacturing company, to address the process development and manufacturing barriers that can impede the successful development of cell and gene therapies. BaseCamp is providing these and other services across ElevateBio’s portfolio companies and selected strategic partners, enabling them to access state of the […]

Servier Pharmaceuticals Puts Down Roots in Seaport District

Posted by ISPE Boston
On May 16, 2019

Servier Pharmaceuticals, a U.S. subsidiary of the global French pharmaceutical company Servier Group, has officially opened its American headquarters in Boston’s new Innovation District. The facility already employs 100 professionals in marketing, business development, R&D and strategic support functions. That figure is projected to double within five years. Servier Group also established the first office […]

Are You Social Media Savvy?

Posted by ISPE Boston
On May 16, 2019

Are you social media savvy? Your skills are needed as part of a group that working with a professional marketing consultant to help bolster the Chapter’s social media presence. The consultant will do all the heavy lifting. No writing is required on your part – just your social media chops and your desire to share […]

Learn How to Polish Your Public Speaking Skills on May 22

Posted by Caren Jenkins
On May 2, 2019

We know you won’t want to miss the public speaking workshop “Presenting Yourself to Success” on Wednesday May 22 at Vertex in the Seaport District. The Boston Area Chapter’s Women in Pharma® (WIP) group is proud to partner with Vertex’s IWILL Diversity and Inclusion Network will host this event. We promise – this is not […]

Women in Pharma®: Networking, Brewery Tours & Moais too!

Posted by Katherine Leitch
On May 2, 2019

Thank you to everyone who attended our Boston Women in Pharma® social event at Night Shift Brewery on April 25, 2019 and a special thank you to CRB for sponsoring the event. We had a fantastic time! In addition to networking, playing Mingle Bingo, taking brewery tours, sampling the Night Shift Brewery beers and eating […]

Welcome New Members!

Posted by ISPE Boston
On May 2, 2019

We would like to introduce the Members who joined ISPE in April 2019, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Chapter Member Anniversaries: April 2019

Posted by ISPE Boston
On May 2, 2019

Please congratulate the following members celebrating milestone anniversaries in April 2019. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years James Araujo, Jr., Lonza Biologics Inc James R. Berry, DPR Construction Inc. Maryellen Brown, Pall Life Sciences Michael S. Cheney, Biogen Idec Donald Cole, Hart Passivation Services, Inc. […]

Alnylam and Regeneron to Collaborate on RNAi Therapeutics

Posted by ISPE Boston
On April 24, 2019

Alnylam and Regeneron have announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics with a focus on disease targets expressed in the eye and central nervous system (CNS), in addition to a select number of targets expressed in the liver. The collaboration will leverage both companies’ scientific and technological expertise and […]

Page 2 of 37‹123 4 ›»

Blog